INM - InMed Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INM is currently covered by 1 analysts with an average price target of $54.91. This is a potential upside of $54.63 (19510.71%) from yesterday's end of day stock price of $0.28.

InMed Pharmaceuticals's activity chart (see below) currently has 0 price targets and 1 ratings on display. The stock rating distribution of INM is 100% HOLD.

Stock Analyst Price Targets - Review

Highest price target for INM is $20, Lowest price target is $20, average price target is $54.91.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 01-Dec-2021. First documented stock forecast 01-Dec-2021.

Best performing analysts who are covering INM - InMed Pharmaceuticals:

Raghuram Selvaraju Scott Henry

Currently out of the existing stock ratings of INM, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

150

$149.41 (25323.73%)

2 years 5 months 8 days ago

0/1 (0%)

$109.25 (268.10%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INM (InMed Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on INM (InMed Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on INM (InMed Pharmaceuticals) with a proven track record?

SCOTT HENRY

Which analyst has the most public recommendations on INM (InMed Pharmaceuticals)?

Raghuram Selvaraju has 3 price targets and 16 ratings on INM

Which analyst is the currently most bullish on INM (InMed Pharmaceuticals)?

Raghuram Selvaraju with highest potential upside - $149.41

Which analyst is the currently most reserved on INM (InMed Pharmaceuticals)?

Scott Henry with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?